Drugs / Atazanavir/Cobicistat
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05236738 | May → Jul 2022 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Atazanavir/Cobicistat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05236738 ↗ |
| Route | Oral | “ATV and COBI Oral Mini-tablets” NCT05236738 ↗ |